Skip to main content
EXO-SKM • RESEARCH USE ONLY

Skeletal Muscle Exosomes

Exosomes from skeletal muscle stem cells containing pro-myogenic and anti-fibrotic factors.

Product image for Skeletal Muscle Exosomes
Satellite-cell EVs
MYOGENIC LINEAGE
— Stem-cell–derived muscle exosomes enriched for pro-myogenic and matrix-modulating factors that mirror regenerative satellite-cell signaling.
Fibrosis down · perfusion up
REPAIR PHENOTYPE
— Facilitates myoblast proliferation, supports angiogenic remodeling, and reduces fibrotic scarring in injured or dystrophic muscle beds.
Atrophy · cachexia · sport
USE-CASE SPREAD
— Application notes include muscular dystrophies, acute injuries, sarcopenia, cachexia, sports medicine, and postoperative muscle volume loss.
ROUTES, FORMATS & APPLICATIONS
Routes
IVIntravenousIMIntramuscular
Quantities
400 Billion Exosomes1ml
Potential Applications

These are experimental use cases, provided as a scientific reference for researchers. Except where noted, they did not use Akira Biotech materials, and results may not be reproducible with ours. Akira Biotech supplies laboratory reagents for research use only. Our products are NOT approved by FDA or any regulatory authority and are not for use in or on humans.

  • Muscular Dystrophies
  • Muscle Injuries
  • Sarcopenia
  • Cachexia
  • Sports medicine / sports injuries
  • Muscle atrophy
  • Post-surgical muscle loss

Compliance · Exosomes

cGMP manufacturing & cryopreservation

Cells are manufactured under cGMP conditions and cryopreserved using a non-toxic, glucose-based method with greater than 98% viability.

cGMPNON-TOXIC CRYOPRESERVATION>98% VIABILITY
Viability & cryopreservation

Cryopreserved using a non-toxic, glucose-based method with greater than 98% viability.

GLUCOSE-BASED CRYO>98% VIABILITY

Explore More

Keep browsing our product lineup